EFFECT OF BILE ACID RECEPTOR (FXR/TGR5) AGONIST INT-767 ON PERIPHERAL IMMUNE CELLS

被引：0
|
作者：
Papackova, Zuzana [1 ]
Heczkova, Marie [1 ]
Dankova, Helena [1 ]
Cahova, Monika [1 ]
机构：
[1] Inst Clin & Expt Med, Prague, Czech Republic
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO033
引用
收藏
页码：E120 / E120
页数：1
相关论文
共 50 条
  • [1] FUNCTIONAL CHARACTERIZATION OF THE SEMI-SYNTHETIC BILE ACID DERIVATIVE INT-767, A DUAL FXR AND TGR5 AGONIST
    Rizzo, Giovanni
    Passeri, Daniela
    De Franco, Francesca
    Ciaccioli, Gianmario
    Donadio, Loredana
    Rizzo, Giorgio
    Orlandi, Stefano
    Sadeghpour, Bahman
    Wang, Xiaoxin
    Jiang, Tao
    Levi, Moshe
    Pruzanski, Mark
    Adorini, Luciano
    HEPATOLOGY, 2010, 52 (04) : 595A - 595A
  • [2] FUNCTIONAL CHARACTERIZATION OF THE SEMI-SYNTHETIC BILE ACID DERIVATIVE INT-767, A DUAL FXR AND TGR5 AGONIST
    Rizzo, G.
    Passeri, D.
    De Franco, F.
    Ciaccioli, G.
    Sadeghpour, B.
    Pellicciari, R.
    Pruzanski, M.
    Adorini, L.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S430 - S431
  • [3] Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
    Rizzo, Giovanni
    Passeri, Daniela
    De Franco, Francesca
    Ciaccioli, Gianmario
    Donadio, Loredana
    Rizzo, Giorgia
    Orlandi, Stefano
    Sadeghpour, Bahman
    Wang, Xiaoxin X.
    Jiang, Tao
    Levi, Moshe
    Pruzanski, Mark
    Adorini, Luciano
    MOLECULAR PHARMACOLOGY, 2010, 78 (04) : 617 - 630
  • [4] The dual FXR/TGR5 agonist INT-767 inhibits nonalcoholic steatohepatitis development in a rabbit model of metabolic syndrome
    Comeglio, Paolo
    Filippi, Sandra
    Cellai, Ilaria
    Maneschi, Elena
    Corcetto, Francesca
    Como, Chiara
    Morelli, Annamaria
    Adorini, Luciano
    Maggi, Mario
    Vianozzi, Linda
    HEPATOLOGY, 2016, 64 : 758A - 759A
  • [5] INT 767: A NOVEL, DUAL FXR AND TGR5 AGONIST, ATTENUATES INTESTINAL ISCHEMIA REPERFUSION INJURY
    Canovai, Emilio
    Farre, Ricard
    Accarie, Alison
    De Hertogh, Gert
    Vanuytsel, Tim
    Pirenne, Jacques
    Ceulemans, Laurens
    TRANSPLANT INTERNATIONAL, 2019, 32 : 409 - 410
  • [6] A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
    Wang, Xiaoxin X.
    Luo, Yuhuan
    Wang, Dong
    Adorini, Luciano
    Pruzanski, Mark
    Dobrinskikh, Evgenia
    Levi, Moshe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (29) : 12018 - 12024
  • [7] The FXR/TGR5 dual agonist INT-767 prevents and reverses Western diet-induced NASH and modulates major lipid metabolic pathways in mice
    Wang, Xiaoxin
    Libby, Andrew
    Ranjit, Suman
    Wang, Dong
    Luo, Yuhuan
    Orlicky, David J.
    McManaman, James
    Dobrinskikh, Evgenia
    Gratton, Enrico
    Young, Mark
    Adorini, Luciano
    Levi, Moshe
    HEPATOLOGY, 2016, 64 : 761A - 762A
  • [8] Detailed Analyses of the Antifibrotic effects of INT-767, a dual FXR/TGR5 agonist, in an obese mouse model of diet-induced and biopsy-confirmed NASH
    Veidal, Sanne Skovgaard
    Feigh, Michael
    Hansen, Henrik B.
    Jelsing, Jacob
    Vrang, Niels
    Petitjean, Matthieu
    Chen, Li
    Young, Mark
    Roth, Jonathan D.
    HEPATOLOGY, 2017, 66 : 1044A - 1044A
  • [9] The dual FXR/TGR5 agonist INT-767 counteracts non-alcoholic steatohepatitis in a rabbit model of high fat diet-induced metabolic syndrome
    Vignozzi, Linda
    Cellai, Ilaria
    Filippi, Sandra
    Comeglio, Paolo
    Sarchielli, Erica
    Morelli, Annamaria
    Maneschi, Elena
    Vannelli, Gabriella Barbara
    Adorini, Luciano
    Maggi, Mario
    HEPATOLOGY, 2015, 62 : 645A - 645A
  • [10] THE DUAL FXR/TGR5 AGONIST INT-767 COUNTERACTS NONALCOHOLIC STEATOHEPATITIS AND ERECTILE DYSFUNCTION IN A RABBIT MODEL OF HIGH FAT DIET-INDUCED METABOLIC SYNDROME
    Vignozzi, L.
    Cellai, I
    Filippi, S.
    Comeglio, P.
    Sarchielli, E.
    Morelli, A.
    Maneschi, E.
    Vannelli, G. B.
    Adorini, L.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (04): : E143 - E144
12345